Corvus Pharmaceuticals
CRVS
CRVS
52 hedge funds and large institutions have $360M invested in Corvus Pharmaceuticals in 2017 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 16 increasing their positions, 17 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
6% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 17
2% less funds holding
Funds holding: 53 → 52 (-1)
Holders
52
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$8.48M | |
| 2 | +$3.8M | |
| 3 | +$3.7M | |
| 4 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
+$1.4M |
| 5 |
Renaissance Technologies
New York
|
+$1.2M |
Top Sellers
| 1 | -$3.73M | |
| 2 | -$2.44M | |
| 3 | -$1.97M | |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$853K |
| 5 |
Millennium Management
New York
|
-$749K |